The histopathological improvements in the AA rat model, paired with the reduction in inflammatory markers, such as TNF-α and IL-6, suggest that BDE is effective in mitigating rheumatoid arthritis pathology through its anti-inflammatory and immunomodulatory effects. Here, IL6 is linked to rheumatoid arthritis.